The Effect of Different Ways of Sitting on Cognitive Performance and Muscle Activity
NCT04716582, Not applicable, Unknown, Maastricht University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Effect of Different Ways of Sitting on Cognitive Performance and Muscle Activity | ClinicalTrials.gov |
| NCT number | NCT04716582 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 21 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Maastricht University | ClinicalTrials.gov |
| Conditions | Sedentary Behavior, Light Intensity Physical Activity | ClinicalTrials.gov |
| Interventions | Sitting interrupted by light physical activity, Sitting with cognitive task, uninterrupted sitting | ClinicalTrials.gov |
| First posted | 2021-01-20 | ClinicalTrials.gov |
| Last updated | 2021-01-20 | ClinicalTrials.gov |
Registered outcomes 14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Cognitive processes as assessed using Stroop test | change from baseline after 4 hour intervention on day1, day8, day16 | Stroop test is a computer-based Stroop word and color test, including congruent trials and incongruent trials to assess inhibition. Reaction time and accuracy of the Stroop test will be collected before and after the intervention | ClinicalTrials.gov |
| Primary | Cognitive processes as assessed using D2 attention test | change from baseline after 4 hour intervention on day1, day8, day16 | D2 attention test is a paper and pencil test to assess attention. Concentration performance will be collected before and after the intervention. | ClinicalTrials.gov |
| Primary | Cognitive processes as assessed using N back test | change from baseline after 4 hour intervention on day1, day8, day16 | N back test is a computer-based test, including target images and non-target images. this test is for updating and working memory. The correct reaction number of N back test will be collected before and after the intervention. | ClinicalTrials.gov |
| Primary | Cognitive processes as assessed using Trail making test | change from baseline after 4 hour intervention on day1, day8, day16 | Trail making test is a computer-based test to assess task-switching. reaction time and accuracy of the trail making test will be collected before and after the intervention. | ClinicalTrials.gov |
| Secondary | mood status assessed by tension score | change from baseline after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | mood status assessed by anger score | change from baseline all mood outcomes after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | mood status assessed by depression score | change from baseline all mood outcomes after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | mood status assessed by vigor score | change from baseline all mood outcomes after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | mood status assessed by esteem-related effect score | change from baseline all mood outcomes after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | mood status assessed by confusion score | change from baseline all mood outcomes after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | mood status assessed by fatigue score | change from baseline all mood outcomes after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | mood status assessed by total mood level score | change from baseline all mood outcomes after 4 hour intervention on day1, day8, day16 | mood questionnaire(an abbreviated version of Profile of Mood States (POMS)) will be used before and after the intervention, such as tension, anger, depression, vigor, esteem-related effect, confusion, fatigue, total mood level data included. The scale is 0 to 4. | ClinicalTrials.gov |
| Secondary | muscle activity | recording 5 minutes' muscle activity for each sitting posture, average RMS will be collected.it will be performed on another experiment day. | Muscle activity is measured by the electromyograph （EMG）machine. RMS values will be collected and calculated as muscle activation during each sittings condition | ClinicalTrials.gov |
| Secondary | discomfort level | report discomfort level immediately after each sitting condition(each sitting posture lasts 5 minutes).it will be performed on another experiment day. | after each sitting condition, self discomfort level will be asked.0 means no discomfort,10 means the worst discomfort | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| 1-Back Task | Primary outcome | ConductCognition |
| 2-Back Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Task Switching Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)